| Pharmaceutical active ingredients: |
| Griseofulvin |
| Available forms, composition and doses of Grifulin Forte: |
| Tablets; Oral; Griseofulvin 125 mg |
| Grifulin Forte medical category: |
| Human:Antifungals |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D01AA08 - GriseofulvinD01BA01 - Griseofulvin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Teva |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Grifor | Virus Strain A(H1N1); Virus Strain A(H3N2) | Fort, Russia; Microgen NPO |
| Grifotaxima | Cefotaxime Sodium | Chile Laboratorios |
| Grifotenol | Atenolol | Chile Laboratorios |
| Grifotriaxona | Ceftriaxone Sodium | Chile Laboratorios |
| Grifulin | Griseofulvin | Teva |
| Grifulvin | Griseofulvin | General Drugs House |
| Grifulvin V | Griseofulvin Microcrystalline | Johnson & Johnson; Ortho McNeil Pharmaceuticals |
| Grilinctus Capsules | Chlorpheniramine Maleate; Dextromethorphan Hydrobromide; Phenylpropanolamine Hydrochloride | Franco-Indian Pharmaceuticals |
| Grilinctus Syrup | Ammonium Chloride; Chlorpheniramine Maleate; Dextromethorphan Hydrobromide; Guaifenesin | Franco-Indian Pharmaceuticals |
| Grilinctus-BM | Bromhexine Hydrochloride; Terbutaline Sulfate | Franco-Indian Pharmaceuticals |